Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
levetiracetam (keppra) (1 trial)
phenytoin (mesantoin) (1 trial)
Brain Injuries (Phase 4)
Brain Injuries, Traumatic (Phase 4)
Hemorrhage (Phase 4)
Seizures (Phase 4)
Subarachnoid Hemorrhage (Phase 4)
Trials (1 total)
Trial APIs (2 total)